Eun Ae Kang

8PUBLICATIONS
30CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical biochemistry - lipidsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 31, 2023
Risk Factors for Surgery in Patients with Intestinal Behçet's Disease During Anti-Tumor Necrosis Factor-Alpha Therapy.

So Jung Han, Eun Ae Kang, Jihye Park

|Aug 23, 2021
Continued Postoperative Use of Tumor Necrosis Factor-α Inhibitors for the Prevention of Crohn's Disease Recurrence.

Jongwook Yu, Hye Kyung Hyun, Jihye Park

|Mar 26, 2021
Prognostic Value of Terminal Ileal Inflammation in Patients with Ulcerative Colitis.

Jongwook Yu, Jihye Park, Eun Ae Kang

|Mar 26, 2021
Long-term Outcomes after the Discontinuation of Anti-Tumor Necrosis Factor-α Therapy in Patients with Inflammatory Bowel Disease under Clinical Remission: A Korean Association for the Study of Intestinal Disease Multicenter Study.

Joo Hye Song, Eun Ae Kang, Soo-Kyung Park

|Nov 07, 2019
Crohn's disease and ulcerative colitis are associated with different lipid profile disorders: a nationwide population-based study.

Hosim Soh, Jong Pil Im, Kyungdo Han

|Mar 16, 2018
Characteristics of cytomegalovirus enterocolitis in patients with or without inflammatory bowel diseases.

Eun Ae Kang, Hyuk Yoon, A Young Seo

Pageof 2

Frequent Collaborators

4 joint publications

Jae Hee Cheon

3 joint publications

Tae Il Kim

3 joint publications

Jae Jun Park

3 joint publications

Won Ho Kim